We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Top Buys

Rank Stock Value
1
FALN icon
iShares Fallen Angels USD Bond ETF
FALN
+$9.31M
2
IEFA icon
iShares Core MSCI EAFE ETF
IEFA
+$6.87M
3
EFTR
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
+$3.6M
4
CORT icon
Corcept Therapeutics
CORT
+$3M
5
SPSB icon
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
+$2.68M

Top Sells

Rank Stock Value
1
ESGV icon
Vanguard ESG US Stock ETF
ESGV
+$9.63M
2
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$7.01M
3
MSFT icon
Microsoft
MSFT
+$5.41M
4
MINT icon
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
+$5.16M
5
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WINT
3301
DELISTED
Windtree Therapeutics
WINT
– –
0
– –
WKHS icon
3302
Workhorse Group
WKHS
$36.3M
– –
0
– -$2K
WMG icon
3303
Warner Music
WMG
$13.8B
– –
-14
Closed -$1K
WPRT
3304
Westport Fuel Systems
WPRT
$35.7M
$0 ﹤0.01%
10
-585
-98% -$10.5K
WRN
3305
Western Copper and Gold
WRN
$544M
$0 ﹤0.01%
6
– –
WTI icon
3306
W&T Offshore
WTI
$518M
– –
-229
Closed -$1K
XJH icon
3307
iShares ESG Screened S&P Mid-Cap ETF
XJH
$433M
– –
-2,836
Closed -$103K
XPRO icon
3308
Expro Ltd
XPRO
$1.91B
– –
-22
Closed –
XXII
3309
22nd Century Group
XXII
$1.48M
– –
0
– –
YMAB
3310
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-16
Closed –
YRD
3311
Yiren Digital
YRD
$110M
– –
-356
Closed -$1K
GTM
3312
ZoomInfo Technologies
GTM
$1.22B
$0 ﹤0.01%
6
-38
-86% -$2.04K
ZLAB icon
3313
Zai Lab
ZLAB
$2.62B
– –
-673
Closed -$42K
QTTB icon
3314
Q32 Bio
QTTB
$464M
– –
-1
Closed –
TRAW icon
3315
Traws Pharma
TRAW
$8.1M
$0 ﹤0.01%
1
– –
AMBR
3316
Amber International Holding Ltd
AMBR
$130M
– –
-155
Closed -$7K
RPT
3317
Rithm Property Trust
RPT
$93.7M
$0 ﹤0.01%
5
– –
BWIN
3318
Baldwin Insurance Group
BWIN
$2.86B
$0 ﹤0.01%
11
– –
SEI
3319
Solaris Energy Infrastructure
SEI
$3.82B
– –
-132
Closed -$1K
ONC
3320
BeOne Medicines Ltd
ONC
$39.4B
– –
-214
Closed -$58K
TVRD
3321
Tvardi Therapeutics
TVRD
$23.4M
– –
0
– –
TPC
3322
Tutor Perini Cor
TPC
$5.21B
$0 ﹤0.01%
43
– –
PTVE
3323
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
– –
-9
Closed –
EDR
3324
DELISTED
Endeavor Group Holdings, Inc.
EDR
$0 ﹤0.01%
+3
New +$91
SILV
3325
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$0 ﹤0.01%
+55
New +$464
131 132
133
134 135

Similar funds

HFS
Hantz Financial Services Southfield, Michigan $6.56B AUM 16.11% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
LAM
Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return
BF
BOK Financial Tulsa, Oklahoma $6.54B AUM 25.41% 1-Year Est. Return
NMIMC
Northwestern Mutual Investment Management Company Milwaukee, Wisconsin $6.6B AUM 19.75% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.